 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Protease Inhibitors (PIs)
Overview | Amprenavir (Agenerase) | Atazanavir (Reyataz) | Darunavir (TMC114, Prezista) | Fosamprenavir (Lexiva, Telzir) | Indinavir (Crixivan) | Lopinavir/Ritonavir (Kaletra) | Nelfinavir (Viracept) | Ritonavir (Norvir) | Saquinavir (Invirase) | Tipranavir (Aptivus) | Drug Interactions | Research | Experimental Drugs
Overview
- Adverse Effects of Antiretroviral Drugs: PIs (November 2007)
A table summarizing the most common and most serious adverse events associated with PIs.
From HIV InSite Knowledge Base Chapter - New HIV Protease Inhibitors: New Options in the PI Class for Treatment-Naive Persons (Spring 2004)
To read PDF, click here
In Resolute!, from PWA Coalition Colorado - HIV 101: Antiretroviral Agents Dosing and Administration Recommendations: PIs (January 2002)
To read PDF, click here
In HEPP News, from Brown Medical School - Dual Protease Inhibitors Gain Ground (Spring 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation - Seeing Double: A Tale of Dual Protease Inhibitors (Spring 2001)
To read PDF, click here
In CRIA Update, from AIDS Community Research Initiative of America
The Basics
- Adverse Effects of Antiretroviral Drugs: PIs (November 2007)
A table summarizing the most common and most serious adverse events associated with PIs.
From HIV InSite Knowledge Base Chapter - New HIV Protease Inhibitors: New Options in the PI Class for Treatment-Naive Persons (Spring 2004)
To read PDF, click here
In Resolute!, from PWA Coalition Colorado - HIV 101: Antiretroviral Agents Dosing and Administration Recommendations: PIs (January 2002)
To read PDF, click here
In HEPP News, from Brown Medical School - Dual Protease Inhibitors Gain Ground (Spring 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation - Seeing Double: A Tale of Dual Protease Inhibitors (Spring 2001)
To read PDF, click here
In CRIA Update, from AIDS Community Research Initiative of America
Overview
- Adverse Effects of Antiretroviral Drugs: PIs (November 2007)
A table summarizing the most common and most serious adverse events associated with PIs.
From HIV InSite Knowledge Base Chapter - New HIV Protease Inhibitors: New Options in the PI Class for Treatment-Naive Persons (Spring 2004)
To read PDF, click here
In Resolute!, from PWA Coalition Colorado - HIV 101: Antiretroviral Agents Dosing and Administration Recommendations: PIs (January 2002)
To read PDF, click here
In HEPP News, from Brown Medical School - Dual Protease Inhibitors Gain Ground (Spring 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation - Seeing Double: A Tale of Dual Protease Inhibitors (Spring 2001)
To read PDF, click here
In CRIA Update, from AIDS Community Research Initiative of America
  |
  |